Fig. 5From: Prediction of high-flow nasal cannula outcomes at the early phase using the modified respiratory rate oxygenation indexThe decision analysis curves of ROX (top left), mROX (top right), ROX-HR (bottom left), and mROX-HR (bottom right) indices at 2 h after HFNC therapy initiation in COVID-19 pneumoniaBack to article page